| Literature DB >> 35079262 |
Mária Adamczyk1, Jarosław Wasilewski1, Jacek T Niedziela1, Michał O Zembala2, Mariusz Gąsior1.
Abstract
INTRODUCTION: Studies on the etiology of cardiac tamponade (CT) are scarce or lacking follow-up, and usually include small or highly selected groups of patients. AIM: To evaluate the various etiologies and outcomes of CT in a cohort of patients treated in a tertiary care hospital encompassing cardiology, cardiac surgery and intensive care units.Entities:
Keywords: cardiac tamponade; iatrogenic; inflammatory; neoplastic; postpericardiotomy syndrome
Year: 2022 PMID: 35079262 PMCID: PMC8768860 DOI: 10.5114/kitp.2021.112187
Source DB: PubMed Journal: Kardiochir Torakochirurgia Pol ISSN: 1731-5530
Figure 1Particular groups of etiologies of 340 cardiac tamponades diagnosed and treated between January 2008 and December 2018
AMI – acute myocardial infarction complication, IC – iatrogenic after invasive cardiac procedures, ICS – iatrogenic after cardiac surgery procedures, PCT – postpericardiotomy syndrome, NPL – neoplastic, INFL – inflammatory.
Baseline characteristics, disease burden and laboratory parameters of patients with different etiologies of cardiac tamponade hospitalized between January 2008 and December 2018
| Parameter | IC ( | ICS ( | PCT ( | NPL ( | INFL ( | UREMIC ( | AMI ( |
|---|---|---|---|---|---|---|---|
| Age [years] | 70 (16.6) | 64 (15) | 58 (15.7) | 57 (13.4) | 57.5 (26) | 65 (17) | 74 (20) |
| Hospital stay [days] | 13 (15) | 25 (13) | 6 (5) | 6 (8) | 16 (17) | 11 (12) | 14 (29) |
| (%) of men | 48 | 55 | 74 | 34 | 53 | 75 | 80 |
| Prior CAD (%) | 44 | 29 | 33 | 8 | 23 | 37.5 | 20 |
| Prior AF (%) | 38 | 39 | 24 | 18 | 25,5 | 62.5 | 0 |
| Prior CHF (%) | 24 | 42 | 55 | 8 | 23 | 50 | 0 |
| Prior AMI (%) | 27 | 16 | 11.5 | 4 | 7 | 12.5 | 40 |
| Prior PAD (%) | 12.5 | 29 | 17 | 4 | 9 | 37.5 | 40 |
| Prior CKD (%) | 12.5 | 10 | 13 | 6 | 14 | 100 | 20 |
| Prior AH (%) | 50 | 48 | 64 | 28 | 28 | 50 | 80 |
| Prior DM (%) | 20 | 13 | 23 | 12 | 12 | 37.5 | 20 |
| Obesity (%) | 7 | 13 | 33 | 2 | 2.3 | 0 | 0 |
| APTT | 35.95 (13.3) | 38.1 (15.3) | 40.2 (13.7) | 34.3 (10.85) | 36.95 (8.1) | 42.1 (12.6) | 71.5 (64.7) |
| PT | 13.5 (2.1) | 13.8 (2.7) | 22.5 (13) | 14.65 (2.9) | 15.05 (2.5) | 16.7 (3.3) | 14.0 (2.2) |
| INR | 1.06 (0.19) | 1.08 (0.257) | 1.99 (1.36) | 1.2 (0.26) | 1.2 (0.26) | 1.37 (0.37) | 1.1 (0.19) |
| GFR | 60.0 (38) | 82.9 (50.34) | 60.0 (35.7) | 60.0 (52.15) | 65.5 (48.4) | 30.5 (11) | 35.9 (10) |
| CREAT [mmol/l] | 87.4 (43.7) | 82.58 (37.5) | 95.2 (50.9) | 83.3 (81) | 83.0 (39.6) | 203.6 (106.9) | 141.0 (62.5) |
| PLT [× 109/l] | 203 (84) | 208 (105) | 343 (262) | 257.5 (150) | 240 (165) | 261.5 (191) | 181 (69) |
| HCT | 0.397 (0.07) | 0.37 (0.08) | 0.32 (0.08) | 0.36 (0.09) | 0.36 (0.1) | 0.38 (0.06) | 0.39 (0.03) |
| HGB [mmol/l] | 8.4 (1.7) | 7.8 (2.1) | 6.40 (1.8) | 7.5 (2.0) | 7.65 (2.4) | 7.7 (1.5) | 8.8 (1.2) |
| RBC [× 1012/l] | 4.4 (0.78) | 4.08 (0.86) | 3.575 (0.99) | 3.92 (0.9) | 4.14 (1.07) | 4.09 (1.35) | 4.5 (0,.32) |
| WBC [× 109/l] | 7.38 (3.5) | 7.86 (3.9) | 10.32 (4.82) | 10.51 (7.27) | 8.07 (5.4) | 7.23 (6.05) | 14.4 (1.7) |
AMI – acute myocardial infarction, NPL – neoplasm, IC – iatrogenic after invasive cardiac procedures, ICS – iatrogenic after cardiosurgery procedures, PCT – postpericardiotomy syndrome, AF – atrial fibrillation, APTT – activated partial thromboplastin time, CAD – coronary artery disease, CHF – chronic heart failure, CKD – chronic kidney disease, CS – cardiac surgery, GFR – glomerular filtration rate, HCT – hematocrit, HGB hemoglobin, INR – international normalized ratio, CREAT – creatinine, MI – myocardial infarction, PAD – peripheral artery disease, PLT – platelets, PT – prothrombin time, RBC – red blood cells, WBC – white blood cells.
In-hospital management of patients with different etiologies of cardiac tamponade hospitalized between January 2008 and December 2018
| Parameter | IC ( | ICS ( | PCT ( | NPL ( | INFL ( | UREMIC ( | AMI ( |
|---|---|---|---|---|---|---|---|
| PCC, | 92 (82%) | 17 (52%) | 47 (60%) | 49 (98%) | 40 (93%) | 7 (87.5%) | 3 (60%) |
| Pericardiotomy, | 16 (14%) | 12 (42%) | 31 (40%) | 0 | 2 (5%) | 1 (12.5%) | 1 (20%) |
| PCC + pericardiotomy, | 4 (4%) | 2 (6%) | 0 | 1 (2%) | 1 (2%) | 0 | 1 (20%) |
| Fenestration, | 1 | 1 | 2 | 3 | 3 | 0 | 0 |
| Inotropes (%) | 28 | 29 | 3 | 6 | 12 | 25 | 80 |
| MVS (%) | 15 | 13 | 1 | 6 | 9 | 12.5 | 60 |
| Data available in x (%) of patients | 76% | 15% | 74% | 90% | 74% | 50% | 60% |
| Drained pericardial fluid – first access [ml] | 320 (360) | 520 (180) | 650 (440) | 655 (510) | 575 (495) | 860 (900) | 550 (350) |
| Drained pericardial fluid – total [ml] | 390 (460) | 600 (465) | 700 (400) | 910 (710) | 630 (860) | 1140 (500) | 1500 (1900) |
AMI – acute myocardial infarction complication, IC – iatrogenic after invasive cardiac procedures, ICS – iatrogenic after cardiosurgery procedures, MVS – mechanical ventilation support, NPL – neoplasm, PCT – postpericardiotomy syndrome, inotropes – sympathomimetic amine therapy, PCC – pericardiocentesis.
Figure 2In-hospital, 30-day, 1-year and 2-year mortality for different etiology groups of patients with cardiac tamponade, hospitalized between January 2008 and December 2018. In-hospital and post-discharge mortality is presented as all-cause crude death rate since hospital admission. For that reason, 30-day, 1-year and 2-year mortality in AMI group remained high
AMI – acute myocardial infarction, CT – cardiac tamponade, NPL – neoplasm, IC – iatrogenic after invasive cardiac procedures, ICS – iatrogenic after cardiac surgery procedures, INFL – inflammatory, PCT – postpericardiotomy syndrome.